Surgical Therapy for Macular Edema: What We Have Learned through the Decades.

Byers Eye Institute, Stanford University, Palo Alto, CA, USA. Department of Ophthalmology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Bascom Palmer Eye Institute, University of Miami, Miami, FL, USA. Department of Ophthalmology, Gazi University School of Medicine, Ankara, Turkey. Department of Ophthalmology, University of Thessaly, Volos, Greece.

Ocular immunology and inflammation. 2019;(8):1242-1250
Full text from:

Abstract

Macular edema is a leading cause of functional visual loss in retinal vascular or ocular inflammatory diseases. Because persistent macular edema can lead to irreversible retinal damage, multi-approached treatment should be considered to achieve complete resolution of macular edema. With an enhanced understanding of its pathophysiology, numerous therapeutic options have been developed for the management of macular edema over the decades. Although medical therapies account for the mainstay of treatment, surgical approaches with vitrectomy can play an important role in the management of macular edema, depending on its mechanism of fluid accumulation. The index review focuses on the efficacy of surgical therapy for macular edema secondary to various ocular diseases including diabetic retinopathy, uveitis, and retinal vein occlusion, and consequently provides the evidences that may expand the knowledge and support the employment of surgical options.

Methodological quality

Publication Type : Review

Metadata

MeSH terms : Macular Edema ; Vitrectomy